Clinical trial
Selpercatinib and Body Composition
NCT07543887 is registered in ClinicalTrials.gov with University of Pisa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Selpercatinib and Body Composition
- Lead sponsor
- University of Pisa
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 12, 2024
- Completion date
- April 4, 2026
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thyroid cancer